Literature DB >> 22690666

Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects?

James B Kirkbride1, Ezra Susser, Marija Kundakovic, Jacob K Kresovich, George Davey Smith, Caroline L Relton.   

Abstract

We posit that maternal prenatal nutrition can influence offspring schizophrenia risk via epigenetic effects. In this article, we consider evidence that prenatal nutrition is linked to epigenetic outcomes in offspring and schizophrenia in offspring, and that schizophrenia is associated with epigenetic changes. We focus upon one-carbon metabolism as a mediator of the pathway between perturbed prenatal nutrition and the subsequent risk of schizophrenia. Although post-mortem human studies demonstrate DNA methylation changes in brains of people with schizophrenia, such studies cannot establish causality. We suggest a testable hypothesis that utilizes a novel two-step Mendelian randomization approach, to test the component parts of the proposed causal pathway leading from prenatal nutritional exposure to schizophrenia. Applied here to a specific example, such an approach is applicable for wider use to strengthen causal inference of the mediating role of epigenetic factors linking exposures to health outcomes in population-based studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22690666      PMCID: PMC3970193          DOI: 10.2217/epi.12.20

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  114 in total

1.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

Review 2.  The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.

Authors:  Dennis R Grayson; Ying Chen; Erminio Costa; Erbo Dong; Alessandro Guidotti; Marija Kundakovic; Rajiv P Sharma
Journal:  Pharmacol Ther       Date:  2006-03-30       Impact factor: 12.310

3.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis.

Authors:  S L Eastwood; P J Harrison
Journal:  Mol Psychiatry       Date:  2003-09       Impact factor: 15.992

5.  Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers.

Authors:  Christine A Stidley; Maria A Picchi; Shuguang Leng; Randy Willink; Richard E Crowell; Kristina G Flores; Huining Kang; Tim Byers; Frank D Gilliland; Steven A Belinsky
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

6.  On the epigenetic regulation of the human reelin promoter.

Authors:  Ying Chen; Rajiv P Sharma; Robert H Costa; Erminio Costa; Dennis R Grayson
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

7.  Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Authors:  Jiajun Shi; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2008-08-20       Impact factor: 4.939

8.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

Authors:  Arturas Petronis; Irving I Gottesman; Peixiang Kan; James L Kennedy; Vincenzo S Basile; Andrew D Paterson; Violeta Popendikyte
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

9.  Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age.

Authors:  Krista S Crider; Eoin P Quinlivan; Robert J Berry; Ling Hao; Zhu Li; David Maneval; Thomas P Yang; Sonja A Rasmussen; Quanhe Yang; Jiang-Hui Zhu; Dale J Hu; Lynn B Bailey
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

10.  A critical role for IGF-II in memory consolidation and enhancement.

Authors:  Dillon Y Chen; Sarah A Stern; Ana Garcia-Osta; Bernadette Saunier-Rebori; Gabriella Pollonini; Dhananjay Bambah-Mukku; Robert D Blitzer; Cristina M Alberini
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

View more
  33 in total

1.  Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.

Authors:  Li Zhu; Xiaoming Wang; Xin-Lei Li; Aaron Towers; Xinyu Cao; Ping Wang; Rachel Bowman; Hyuna Yang; Jennifer Goldstein; Yi-Ju Li; Yong-Hui Jiang
Journal:  Hum Mol Genet       Date:  2013-11-01       Impact factor: 6.150

Review 2.  Epigenetic medicine and fetal alcohol spectrum disorders.

Authors:  Marisol Resendiz; Yuanyuan Chen; Nail C Oztürk; Feng C Zhou
Journal:  Epigenomics       Date:  2013-02       Impact factor: 4.778

Review 3.  Folate and epigenetic mechanisms in neural tube development and defects.

Authors:  Sivan Vadakkadath Meethal; Kirk J Hogan; Chandra S Mayanil; Bermans J Iskandar
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

4.  Degree of methylation of ZAC1 (PLAGL1) is associated with prenatal and post-natal growth in healthy infants of the EDEN mother child cohort.

Authors:  Salah Azzi; Theo C J Sas; Yves Koudou; Yves Le Bouc; Jean-Claude Souberbielle; Patricia Dargent-Molina; Irène Netchine; Marie-Aline Charles
Journal:  Epigenetics       Date:  2013-12-06       Impact factor: 4.528

5.  Prenatal protein malnutrition decreases KCNJ3 and 2DG activity in rat prefrontal cortex.

Authors:  A C Amaral; M Jakovcevski; J A McGaughy; S K Calderwood; D J Mokler; R J Rushmore; J R Galler; S A Akbarian; D L Rosene
Journal:  Neuroscience       Date:  2014-11-18       Impact factor: 3.590

Review 6.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

7.  Postnatal risk environments, epigenetics, and psychosis: putting the pieces together.

Authors:  Marija Kundakovic
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-29       Impact factor: 4.328

Review 8.  S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Authors:  Jin Gao; Catherine M Cahill; Xudong Huang; Joshua L Roffman; Stefania Lamon-Fava; Maurizio Fava; David Mischoulon; Jack T Rogers
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 9.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Authors:  Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2016-04-09       Impact factor: 8.989

10.  Mendelian randomization: applications and limitations in epigenetic studies.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Epigenomics       Date:  2015-12-07       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.